This inventor holds 1 USPTO granted patent. Top assignee: Ligand Pharmaceuticals, Inc.. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Amy L. Faulkner: Innovator in RXR Modulation
Introduction
Amy L. Faulkner is a distinguished inventor based in San Diego, California, known for her contributions to the field of pharmacology. With one patent to her name, she has made significant advancements in the development of RXR modulators. Her work focuses on enhancing the pharmacologic profile of these compounds, paving the way for improved therapeutic options.
Latest Patents
Faulkner's patent, titled "RXR modulators with improved pharmacologic profile," presents a novel class of RXR modulator compounds. These compounds showcase an enhanced pharmacological profile compared to previously studied RXR modulators. In her patent, Faulkner also details synthetic methods for preparing these innovative compounds, alongside pharmaceutical compositions that incorporate them. The patent further elaborates on therapeutic uses for these compounds and compositions, emphasizing their potential in medical applications.
Career Highlights
Amy L. Faulkner is currently associated with Ligand Pharmaceuticals, Inc., where she continues to contribute to groundbreaking research in pharmacology. Her innovative mindset and expertise have positioned her as a valuable asset to her team. Throughout her career, Faulkner has remained dedicated to advancing scientific knowledge and improving healthcare solutions.
Collaborations
In her professional journey, Faulkner has collaborated with esteemed colleagues, including Robert J. Ardecky and Marcus F. Boehm. Together, they work to create and refine compound formulations, enhancing their therapeutic applications. Their collective efforts contribute significantly to the progress in RXR modulation and related fields.
Conclusion
Amy L. Faulkner exemplifies the spirit of innovation in the pharmaceutical industry. With her invaluable contributions to RXR modulators, she continues to inspire fellow inventors and researchers. As advancements in medicine and pharmacology progress, inventions like hers play a crucial role in enhancing patient care and treatment outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile